In a prospective phase II Food and Drug Administration trial, robotic mitral valve repairs were performed in 112 patients at 10 centers by using the da Vinci surgical system.
Newly innovated mini-mitral valve surgical instruments and techniques facilitate both direct-vision and endoscopic-assisted approaches and accomplish a favorable surgical outcome even in the complex pathology of mitral valve insufficiency.
